A Phase II Clinical Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2019
At a glance
- Drugs Napabucasin (Primary) ; Capecitabine; Cetuximab; Panitumumab
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Boston Biomedical
- 26 Mar 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Jul 2019.
- 22 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 13 Nov 2017 Status changed from recruiting to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History